Elypta logotype

Elypta

The first Metabolism-based liquid biopsy.

Elypta is developing the first-ever metabolism-based liquid biopsy platform for early detection and closer follow-up of multiple cancer indications. The platform is inherently safe and convenient, exceptionally sensitive in studies to date and affordable assay technology allows for broad use.